| A Beautiful Beginning: Look like a Knock Out by the New Year
It's almost natural to think of winter as being a dark and sometimes dull season. But adopting the right beauty measures and making them a routine can keep you looking vibrant no matter how drab it gets outside. From skincare to great hair, just a few changes can make a big difference.Face value. One of the hottest skin treatments available right now is the micro peel, and it's no wonder. "They're the most result driven because they turn over cellular buildup and make the clarity of skin a lot lighter and look a lot fresher," says Celeste Bullar, esthetician from Egyptian Revival Day Spa, in Carterville."Micro peels are good for not only dry skin, but also acne," she says. "Skin clarity is also improved through other procedures such as full or mini facials, and a variety of body wraps."Protecting skin from the sun is important in the winter, too.
Dynavax Reports Progress in Lupus Program With Inhibitor of TLR7 and ...
BERKELEY, Calif., Nov. 26 /PRNewswire-FirstCall/ -- In a paper appearing online in the December issue of The European Journal of Immunology (Vol. 37, Issue 12), Dynavax scientists report the results of studies made possible under a grant from the Alliance for Lupus Research (ALR). In the article entitled, "Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms", the data show that Dynavax's proprietary IRS 954, a specific inhibitor of two Toll-like receptors, TLR7 and TLR9, can prevent progression of disease when injected in the lupus prone (NZBxNZW)F1 mice. The authors observed a significant reduction of serum levels of nucleic acid specific autoantibodies, the hallmark of systemic lupus erythematosus.
Most Popular
Dennis Wilenchik issued hugely invasive subpoenas to New Times without grand jury review Pervgate The congressional page scandal's proving the straw that breaks the elephant's back, and Congressman Jim Kolbe's got explaining to do Unequal Justice County Attorney Andrew Thomas lives up to his rep by throwing the book at a young Latino motorist while letting cops off easy Thunder Road Luciano Arriaga Jr. was born defiant. Falsely arrested by a nerve-frayed cop, he'd sooner take a chance on resuming his 10-year prison sentence than accept a plea bargain
Commentary Recent Articles By Jim Larkin .
Local attorney, founder of firm dies of cancer Mainor worked for FBI ...
Prominent local attorney Randall "Randy" Mainor, who was a founding partner of the Las Vegas firm Mainor Eglet Cottle, died Tuesday from prostate cancer. He was 66. Mainor had worked as a special agent for the FBI and as a criminal prosecutor with the Clark County district attorney's office before going into private practice. Mainor's career included several multimillion dollar personal injury cases, including a $25 million award in 1999 for a Las Vegas man who was injured when a bus lift prematurely activated, tumbling the man from his wheelchair. Mainor was named Trial Lawyer of the Year in 1999. .
Antarctic Challenge For Cancerbackup, UK
Peter Clutterbuck is setting out this week on an Antarctic expedition aiming to climb some of the unclimbed peaks in the Ellsworth mountains to raise money for the cancer information charity Cancerbackup. He will be accompanied by Simon Garrod a former British Antarctic Survey commander and now a professional mountain guide.
Peter is raising money for Cancerbackup because of the support he has received from the charity when a number of close family members have been diagnosed with cancer. This includes his mother who sadly died from the disease and his wife, Bonnie who is currently receiving treatment for breast cancer.
Peter is an experienced mountaineer and sailor with previous expeditions including climbing in the Alps, Andes, Himalayas and Arctic Greenland and sailing across both the Atlantic and Pacific oceans.
Biotech firms courting investors
For 11 years, TransMolecular Inc. has been working on a promising brain cancer treatment from a substance found in scorpion venom. Now TransMolecular, which has already raised $43 million in venture capital, hopes to raise additional funding as it embarks on pivotal clinical trials to prove the drug is safe and effective - a critical step needed to win approval to market the drug in the United States. "For the last two years, we've tried to keep our head down," said TransMolecular chief executive E. Michael Egan. "Now it's time to put our heads back up." TransMolecular, based in Cambridge, is one of about three dozen local biotech companies slated to speak at the Massachusetts Biotechnology Council's annual investor conference in Boston Thursday, an opportunity for small to midsize growth companies to court potential investors and partners.
Tyler's passion for carving turns into a whale of an exhibit
It seems acquaintances like these have been helpful guides on Mr. Tyler's way to proficiency when it comes to woodcarving. On a visit to a friend who carves cigar store Indians, Mr. Tyler asked how he went about the detailed job. "He said 'I take a piece of wood and start carving and take out everything that doesn't look like an Indian," he said. Another friend who repairs and reconditions pianos proved to be a valuable source of material. He had a pile of old ivory keys that had been removed from pianos dating to the turn of the 20th century and earlier.
"They don't use ivory anymore. He gave me a bundle of them. I use them sparingly. Those pieces of ivory are probably 120 or 130 years old," said Mr. Tyler, who uses the ivory as accents for his carvings. Another source of aged materials has come from the former Grange building in Fairhaven, which is now owned by Mr.
Northwest Biotherapeutics, Inc. Announces Appointment of Chief ...
BETHESDA, Md., Oct. 2 /PRNewswire-FirstCall/ -- Northwest Biotherapeutics, Inc. (OTCBulletinBoard: NWBO) announced today that Anthony P. Deasey, 58, has been appointed as the Company's Senior Vice President of Finance and Chief Financial Officer, and has been elected to the Board of Directors. Prior to joining NWBT, from November 2000 to September 2007 Mr. Deasey served as Executive Vice President, Chief Financial and Chief Operating Officer of Celsion Corporation, a biotechnology company headquartered in Columbia, Maryland. At Celsion, Mr. Deasey played a key role in transitioning Celsion from a medical device to an oncology drug development company, and acquired substantial experience with oncology regulatory and market factors. In addition to Celsion, Mr. Deasey previously served as Chief Financial Officer of two public companies with domestic and international operations and a diverse range of products with up to $800 million in revenues.
|
